The sections highlight the tighter packing of the drug-resistant Eμ-myc/p53-/- cells compared to the drug-sensitive Eμ-myc/Arf-/- in the samples taken in the middle of the tumor (S3C and S3D Fig). This evidence concerns the gene CDKN2A and neoplasm.